Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open, Multi-center, Phase III Study of S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment in Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma Patients

NCT01824459 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT01824459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01824459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open, Multi-center, Phase III Study of S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment in Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma Patients
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
December 1, 2018
Enrollment
576 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer